Jorge Quiroga Vila-rekin lankidetzan egindako argitalpenak (9)

2013

  1. Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure

    PLoS ONE, Vol. 8, Núm. 1

2006

  1. Insulin-like growth factor 1 improves intestinal barrier function in cirrhotic rats

    Gut, Vol. 55, Núm. 9, pp. 1306-1312

2002

  1. Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I

    International Journal of Biochemistry and Cell Biology, Vol. 34, Núm. 3, pp. 242-252

  2. Effect of ursodeoxycholic acid on methionine adenosyltransferase activity and hepatic glutathione metabolism rats

    Gut, Vol. 50, Núm. 5, pp. 701-706

1997

  1. Enhanced urinary excretion of cGMP in liver cirrhosis: Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion

    Digestive Diseases and Sciences, Vol. 42, Núm. 7, pp. 1416-1420

  2. S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: A study with isolated and perfused rat liver

    Hepatology, Vol. 26, Núm. 2, pp. 330-335

1995

  1. Taurocholate-stimulated leukotriene C4 biosynthesis and leukotriene C4-stimulated choleresis in isolated rat liver

    Gastroenterology, Vol. 108, Núm. 6, pp. 1793-1801

1992

  1. Role of leukotrienes B4 and C4 in liver allograft rejection.

    Transplant international : official journal of the European Society for Organ Transplantation, Vol. 5 Suppl 1

1991

  1. Renal prostacyclin influences renal function in non-azotemic cirrhotic patients treated with furosemide

    Journal of Hepatology, Vol. 12, Núm. 2, pp. 170-175